These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26825860)

  • 21. A proposed simplified definition of metabolic syndrome in children and adolescents: a global perspective.
    Zong X; Kelishadi R; Kim HS; Schwandt P; Matsha TE; Mill JG; Caserta CA; Medeiros CCM; Kollias A; Whincup PH; Pacifico L; López-Bermejo A; Zhao M; Zheng M; Xi B
    BMC Med; 2024 May; 22(1):190. PubMed ID: 38715060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Anthropometric and Atherogenic Indices as Screening Tools of Metabolic Syndrome in the Kazakh Adult Population in Xinjiang.
    Zhang XH; Zhang M; He J; Yan YZ; Ma JL; Wang K; Ma RL; Guo H; Mu LT; Ding YS; Zhang JY; Liu JM; Li SG; Niu Q; Rui DS; Guo SX
    Int J Environ Res Public Health; 2016 Apr; 13(4):428. PubMed ID: 27092520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New anthropometric indices in the definition of metabolic syndrome in pediatrics.
    Fazeli M; Mohammad-Zadeh M; Darroudi S; Meshkat Z; Moslem A; Ghazizadeh H; Kargozar S; Ferns G; Bahrami-Taghanaki H; Ghayour-Mobarhan M
    Diabetes Metab Syndr; 2019; 13(3):1779-1784. PubMed ID: 31235094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Adolescent metabolic phenotypes and early adult metabolic syndrome: Tehran lipid and glucose study".
    Hosseinpanah F; Salehpour M; Asghari G; Barzin M; Mirmiran P; Hatami H; Azizi F
    Diabetes Res Clin Pract; 2015 Aug; 109(2):287-92. PubMed ID: 26026779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions.
    Tabatabaei-Malazy O; Saeedi Moghaddam S; Rezaei N; Sheidaei A; Hajipour MJ; Mahmoudi N; Mahmoudi Z; Dilmaghani-Marand A; Rezaee K; Sabooni M; Razi F; Kompani F; Delavari A; Larijani B; Farzadfar F
    PLoS One; 2021; 16(3):e0241926. PubMed ID: 33657130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.
    Subramani SK; Mahajan S; Chauhan P; Yadav D; Mishra M; Pakkirisamy U; Prasad GBKS
    Diabetes Metab Syndr; 2019; 13(1):816-821. PubMed ID: 30641814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the association of two metabolic syndrome definitions, NCEP ATP III and IDF, with the risk of developing atherosclerotic cardiovascular disease: An analytical cross-sectional study.
    Yousefzadeh G; Sayyadi A; Najafipour H; Sabaghnejad V; Pezeshki S
    Endocrinol Diabetes Metab; 2024 Jan; 7(1):e468. PubMed ID: 38268305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of metabolic syndrome prevalence using four different definitions - a population-based study in Finland.
    Haverinen E; Paalanen L; Palmieri L; Padron-Monedero A; Noguer-Zambrano I; Sarmiento Suárez R; Tolonen H;
    Arch Public Health; 2021 Dec; 79(1):231. PubMed ID: 34949223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of the metabolic syndrome using ATP-derived definitions and its relation to insulin-resistance in a cohort of Italian outpatient children.
    Di Bonito P; Forziato C; Sanguigno E; Di Fraia T; Saitta F; Iardino MR; Capaldo B
    J Endocrinol Invest; 2010 Dec; 33(11):806-9. PubMed ID: 20220295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying the metabolic syndrome in obese children and adolescents: do age and definition matter?
    van Vliet M; von Rosenstiel IA; Schindhelm RK; Brandjes DP; Beijnen JH; Diamant M
    Curr Clin Pharmacol; 2009 Sep; 4(3):233-8. PubMed ID: 19500071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.
    Koutsovasilis A; Protopsaltis J; Triposkiadis F; Kokkoris S; Milionis HJ; Zairis MN; Skoularigis J; Koukoulis G; Korantzopoulos P; Melidonis A; Foussas SG
    Intern Med; 2009; 48(4):179-87. PubMed ID: 19218766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reliability of the National Cholesterol Education Program's Adult Treatment Panel III (NCEP/ATP III) and the International Diabetes Federation (IDF) definitions in diagnosing metabolic syndrome (MetS) among Gaza Strip Palestinians.
    Sirdah MM; Abu Ghali AS; Al Laham NA
    Diabetes Metab Syndr; 2012; 6(1):4-8. PubMed ID: 23014247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PREVALENCE OF METABOLIC SYNDROME AMONG ADOLESCENTS IN A CITY IN THE MEDITERRANEAN AREA: COMPARISON OF TWO DEFINITIONS.
    Galera-Martínez R; García-García E; Vázquez-López MÁ; Ortiz-Pérez M; Ruiz-Sánchez AM; Martín-González M; Garrido-Fernández P; Bonillo-Perales A
    Nutr Hosp; 2015 Aug; 32(2):627-33. PubMed ID: 26268091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population.
    Hadaegh F; Ghasemi A; Padyab M; Tohidi M; Azizi F
    Diabetes Res Clin Pract; 2008 May; 80(2):328-34. PubMed ID: 18282630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of metabolic syndrome in urban Colombian adolescents aged 10-16 years using three different pediatric definitions.
    Suárez-Ortegón MF; Ramírez-Vélez R; Mosquera M; Méndez F; Aguilar-de Plata C
    J Trop Pediatr; 2013 Apr; 59(2):145-9. PubMed ID: 23104562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort.
    Zibaeenezhad MJ; Sayadi M; Karimi-Akhormeh A; Ardekani A; Parsa N; Razeghian-Jahromi I
    BMJ Open; 2022 Feb; 12(2):e058333. PubMed ID: 35168988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dynamics of metabolic syndrome development from its isolated components among iranian children and adolescents: Findings from 17 Years of the Tehran Lipid and Glucose Study (TLGS).
    Bagheri P; Khalil D; Seif M; Khedmati Morasae E; Bahramali E; Azizi F; Rezaianzadeh A
    Diabetes Metab Syndr; 2021; 15(1):99-108. PubMed ID: 33321311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
    Kastorini CM; Panagiotakos DB; Georgousopoulou EN; Laskaris A; Skourlis N; Zana A; Chatzinikolaou C; Chrysohoou C; Puddu PE; Tousoulis D; Stefanadis C; Pitsavos C;
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):223-31. PubMed ID: 26803591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.